EU-wide tender
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance sulfasalazine (excl. FMR, N2), ATC M01CX02 for the period 01.11.26-31.10.28 (plus extension option 1x12 months)
Original title: Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Sulfasalazin (ausschl. FMR, N2), ATC M01CX02 f. d. Z. 01.11.26-31.10.28 (zzgl. V.-Option 1x12 Mon)
“Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substance sulfasalazine (excl. FMR, N2), ATC M01CX02 for the period 01.11.26-31.10.28 (plus extension option 1x12 months)” is a eu-wide public tender. Offers are due by Wednesday, 5 September 2029, in 1039 days. Procedure: Open procedure, published EU-wide (above the EU thresholds).
- Deadline
- 5 September 2029, 1039 days left, 12:00
- Published
- 18 September 2026
- Procedure
- Open procedure
- Notice
- EU-wide (TED)
- Type of contract
- Supplies
- Estimated value
- not published
- Place of performance
- not stated
- Source, last checked
- TED, 1 November 2026
Contracting authority and documents
Contracting authority only with access
Original notice (German)Tender documents on the procurement platformIn short
DAK-Gesundheit is concluding a discount agreement for the medicinal product sulfasalazine.
- Discount agreement for the active substance sulfasalazine, ATC M01CX02.
- Contract term from 1 November 2026 to 31 October 2028 with extension option.
- Open procedure, pharmaceutical companies may join at any time.
- Documents to be submitted by email to [email protected].
- The subject of the contract is medicinal products containing the active substance sulfasalazine.
Summary made from the German notice and checked against it; the German original is authoritative.
Questions and answers
When is the deadline for offers?
Until Wednesday, 5 September 2029, 1039 days left. The exact time and how to submit are in the original notice, which is authoritative.
Which rules apply?
German procurement law implementing the EU directives (GWB and VgV; for works VOB/A EU).
In which language are the documents and the offer?
Expect German. The accepted languages are stated in the notice, and certificates in another language may have to be submitted with a translation.
Is this tender open to foreign companies?
Yes. Because it is above the EU thresholds, the procedure follows the EU directives, which rule out discrimination by nationality. Suitability can first be shown with the European Single Procurement Document (ESPD).
Key points for a bid
The contract runs for 24 months. The notice links the tender documents directly.
Dates of this tender
| Published | Friday, 18 September 2026 |
|---|---|
| Deadline | Wednesday, 5 September 2029, 12:00 |
| Tender validity ends (calculated) | Friday, 5 October 2029 |
Contract and procedure
| Duration | 24 months |
|---|---|
| Framework agreement | no |
| Tender validity | 1 month after the deadline |
| Suitable for SMEs | not stated |
| Security deposit | not required |
| Legal basis | GWB and VgV (German law implementing the EU directives) |
Service by CPV code
- 33600000 Pharmaceutical products
Sources
Notice: TED, Amtsblatt der Europäischen Union, retrieved 1 November 2026. All information without guarantee; the original notice is authoritative.